It’s what’s missing in the tumour genome, not what’s mutated, that thwarts treatment of metastatic melanoma with immune checkpoint blockade drugs, researchers at The University of Texas MD Anderson Cancer Center report in Science Translational...
from #AlexandrosSfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/2lfavTO
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου